Drug Shortage Report for SANDOZ CIPROFLOXACIN
Report ID | 184619 |
Drug Identification Number | 02387131 |
Brand name | SANDOZ CIPROFLOXACIN |
Common or Proper name | CIPROFLOXACIN |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | CIPROFLOXACIN |
Strength(s) | 0.3% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 5ML |
ATC code | S01AE |
ATC description | ANTIINFECTIVES |
Reason for shortage | Shortage of an inactive ingredient or component. |
Anticipated start date | |
Actual start date | 2023-02-14 |
Estimated end date | 2023-04-07 |
Actual end date | 2023-04-04 |
Shortage status | Resolved |
Updated date | 2023-04-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2023-04-05 | English | Compare |
v8 | 2023-04-04 | French | Compare |
v7 | 2023-04-04 | English | Compare |
v6 | 2023-03-13 | French | Compare |
v5 | 2023-03-13 | English | Compare |
v4 | 2023-02-15 | English | Compare |
v3 | 2023-02-14 | French | Compare |
v2 | 2023-02-14 | English | Compare |
v1 | 2023-02-14 | English | Compare |
Showing 1 to 9 of 9